Seelos Therapeutics, Inc. SEEL
0.37 USD +0.37
Day range unavailable
52-week range unavailable
- YTD
- -71.09%
- 1 year
- -71.09%
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 2.20M | 0 | 0 | 0 | 375.00K | |
| 2.20M | 0 | 0 | 0 | 375.00K | |
| -40.50M | -70.92M | -61.67M | -18.76M | -29.75M | |
| -37.88M | -73.53M | -66.05M | -19.10M | -51.26M | |
| -61.84 | -165.92 | -175.20 | -103.20 | -604.80 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 3.00M | 15.53M | 78.73M | 15.66M | 10.26M | |
| 5.42M | 22.75M | 83.50M | 17.49M | 11.10M | |
| 38.93M | 33.36M | 26.18M | 14.92M | 11.10M | |
| 14.23M | 20.12M | 18.96M | 9.72M | 0 | |
| -33.51M | -10.61M | 57.32M | 2.57M | -7.00K |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -23.91M | -61.60M | -48.99M | -20.91M | -19.30M | |
| 11.38M | -1.60M | 112.07M | 26.31M | 29.52M | |
| -12.54M | -63.20M | 63.07M | 5.40M | 10.22M |